OVID
Ovid Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OVID Filings
Filing Date
Form Description
Form Type
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-07
Form DEF 14A - Other definitive proxy statements
Key Events
2025-11-07 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-10-28
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-10-28 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-10-27
Form PREM14A - Preliminary proxy statements relating to merger or acquisition
2025-10-27 ·
Form PREM14A - Preliminary proxy statements relating to merger or acquisition
2025-10-03
Form 8-K - Current report
Key Events
2025-10-03 · Key Events
Form 8-K - Current report
2025-09-16
Form 8-K - Current report
Key Events
2025-09-16 · Key Events
Form 8-K - Current report
2025-08-13
Form 8-K - Current report
Key Events
2025-08-13 · Key Events
Form 8-K - Current report
2025-08-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-07-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-07-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
